Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-25-000095
Filing Date
2025-01-03
Accepted
2025-01-03 14:16:38
Documents
1
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3649
  Complete submission text file 0001654954-25-000095.txt   5217
Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Issuer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZOMEDICA CORP 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR MI 48108
Business Address
Jordan Scott (Reporting) CIK: 0001769747 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38298 | Film No.: 25505272